Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphatidylinositol 3-kinase inhibitor activity	WDR81 WDR91 RUBCN	9.94e-06	8	114	3	GO:0141039
GeneOntologyMolecularFunction	phosphatidylinositol 3-kinase regulator activity	WDR81 WDR91 RUBCN	1.39e-04	18	114	3	GO:0035014
GeneOntologyCellularComponent	extracellular matrix	TPSAB1 NTN3 APLP1 ADAMTS13 SSPOP FBN1 PXDN MEGF6 PCSK6 PLOD1 MUC6 FBN3 TPSB2	6.02e-05	656	114	13	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	TPSAB1 NTN3 APLP1 ADAMTS13 SSPOP FBN1 PXDN MEGF6 PCSK6 PLOD1 MUC6 FBN3 TPSB2	6.21e-05	658	114	13	GO:0030312
Domain	-	FSTL3 FBN1 FBN3	1.15e-05	8	112	3	3.90.290.10
Domain	TB_dom	FSTL3 FBN1 FBN3	1.72e-05	9	112	3	IPR017878
Domain	TB	FSTL3 FBN1 FBN3	1.72e-05	9	112	3	PS51364
Domain	RNA_pol_Rpb1_2	POLR1A POLR2A	1.07e-04	3	112	2	PF00623
Domain	RNA_pol_asu	POLR1A POLR2A	1.07e-04	3	112	2	IPR000722
Domain	RNA_pol_N	POLR1A POLR2A	1.07e-04	3	112	2	IPR006592
Domain	RNA_pol_Rpb1_1	POLR1A POLR2A	1.07e-04	3	112	2	PF04997
Domain	RNA_pol_Rpb1_5	POLR1A POLR2A	1.07e-04	3	112	2	PF04998
Domain	RNA_pol_Rpb1_3	POLR1A POLR2A	1.07e-04	3	112	2	PF04983
Domain	RNA_pol_Rpb1_4	POLR1A POLR2A	1.07e-04	3	112	2	PF05000
Domain	DUF3446	EGR2 EGR3	1.07e-04	3	112	2	PF11928
Domain	RPOLA_N	POLR1A POLR2A	1.07e-04	3	112	2	SM00663
Domain	RNA_pol_Rpb1_4	POLR1A POLR2A	1.07e-04	3	112	2	IPR007083
Domain	RNA_pol_Rpb1_5	POLR1A POLR2A	1.07e-04	3	112	2	IPR007081
Domain	RNA_pol_Rpb1_1	POLR1A POLR2A	1.07e-04	3	112	2	IPR007080
Domain	RNA_pol_Rpb1_3	POLR1A POLR2A	1.07e-04	3	112	2	IPR007066
Domain	DUF3446	EGR2 EGR3	1.07e-04	3	112	2	IPR021849
Domain	FBN	FBN1 FBN3	1.07e-04	3	112	2	IPR011398
Domain	Znf_C2H2/integrase_DNA-bd	ZNF142 ZNF473 OVOL3 ZNF397 ZNF230 ZNF675 EGR2 EGR3 ZNF558 SP6 PRDM12 ZNF687 ZNF304	2.66e-04	694	112	13	IPR013087
Domain	Growth_fac_rcpt_	NTN3 FBN1 MEGF6 PCSK6 SCUBE3 FBN3	3.56e-04	156	112	6	IPR009030
Domain	cEGF	FBN1 SCUBE3 FBN3	4.94e-04	26	112	3	PF12662
Domain	cEGF	FBN1 SCUBE3 FBN3	4.94e-04	26	112	3	IPR026823
Domain	TB	FBN1 FBN3	7.34e-04	7	112	2	PF00683
Domain	ZINC_FINGER_C2H2_2	ZNF142 ZNF473 OVOL3 ZNF397 ZNF230 ZNF675 EGR2 EGR3 ZNF558 SP6 PRDM12 ZNF687 ZNF304	7.53e-04	775	112	13	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF142 ZNF473 OVOL3 ZNF397 ZNF230 ZNF675 EGR2 EGR3 ZNF558 SP6 PRDM12 ZNF687 ZNF304	7.71e-04	777	112	13	PS00028
Domain	EGF_1	NTN3 SSPOP NTNG2 FBN1 MEGF6 SCUBE3 FBN3	8.74e-04	255	112	7	PS00022
Domain	zf-C2H2	ZNF142 ZNF473 ZNF397 ZNF230 ZNF675 EGR2 EGR3 ZNF558 SP6 PRDM12 ZNF687 ZNF304	9.22e-04	693	112	12	PF00096
Domain	Znf_C2H2-like	ZNF142 ZNF473 OVOL3 ZNF397 ZNF230 ZNF675 EGR2 EGR3 ZNF558 SP6 PRDM12 ZNF687 ZNF304	9.63e-04	796	112	13	IPR015880
Domain	Znf_C2H2	ZNF142 ZNF473 OVOL3 ZNF397 ZNF230 ZNF675 EGR2 EGR3 ZNF558 SP6 PRDM12 ZNF687 ZNF304	1.07e-03	805	112	13	IPR007087
Domain	EGF_2	NTN3 SSPOP NTNG2 FBN1 MEGF6 SCUBE3 FBN3	1.09e-03	265	112	7	PS01186
Domain	ZnF_C2H2	ZNF142 ZNF473 OVOL3 ZNF397 ZNF230 ZNF675 EGR2 EGR3 ZNF558 SP6 PRDM12 ZNF687 ZNF304	1.10e-03	808	112	13	SM00355
Domain	EGF_Lam	NTN3 NTNG2 MEGF6	1.19e-03	35	112	3	SM00180
Domain	Laminin_EGF	NTN3 NTNG2 MEGF6	1.19e-03	35	112	3	PF00053
Domain	Laminin_EGF	NTN3 NTNG2 MEGF6	1.52e-03	38	112	3	IPR002049
Domain	EGF_CA	FBN1 MEGF6 SCUBE3 FBN3	1.78e-03	86	112	4	PF07645
Domain	VWF_dom	SSPOP PXDN MUC6	2.03e-03	42	112	3	IPR001007
Domain	C8	SSPOP MUC6	2.26e-03	12	112	2	PF08742
Domain	TIL	SSPOP MUC6	2.26e-03	12	112	2	PF01826
Domain	Galactose-bd-like	NTN3 ZZEF1 SSPOP PCSK6	2.47e-03	94	112	4	IPR008979
Domain	-	ZNF142 ZNF473 ZNF397 ZNF230 ZNF675 EGR2 EGR3 ZNF558 SP6 PRDM12 ZNF304	2.55e-03	679	112	11	3.30.160.60
Domain	Unchr_dom_Cys-rich	SSPOP MUC6	2.66e-03	13	112	2	IPR014853
Domain	C8	SSPOP MUC6	2.66e-03	13	112	2	SM00832
Domain	EGF_Ca-bd_CS	FBN1 MEGF6 SCUBE3 FBN3	2.77e-03	97	112	4	IPR018097
Domain	TPR-like_helical_dom	POLR1A WFS1 TEX11 TTC19 EDRF1 CFAP46	2.82e-03	233	112	6	IPR011990
Domain	EGF	NTNG2 FBN1 MEGF6 PCSK6 SCUBE3 FBN3	2.94e-03	235	112	6	SM00181
Domain	EGF_3	SSPOP NTNG2 FBN1 MEGF6 SCUBE3 FBN3	2.94e-03	235	112	6	PS50026
Domain	EGF_CA	FBN1 MEGF6 SCUBE3 FBN3	2.98e-03	99	112	4	PS01187
Domain	ASX_HYDROXYL	FBN1 MEGF6 SCUBE3 FBN3	3.09e-03	100	112	4	PS00010
Domain	TIL_dom	SSPOP MUC6	3.09e-03	14	112	2	IPR002919
Domain	EGF-type_Asp/Asn_hydroxyl_site	FBN1 MEGF6 SCUBE3 FBN3	3.81e-03	106	112	4	IPR000152
Domain	EGF-like_dom	NTNG2 FBN1 MEGF6 PCSK6 SCUBE3 FBN3	3.90e-03	249	112	6	IPR000742
Domain	VWF_type-D	SSPOP MUC6	4.05e-03	16	112	2	IPR001846
Domain	Laminin_N	NTN3 NTNG2	4.05e-03	16	112	2	IPR008211
Domain	VWFD	SSPOP MUC6	4.05e-03	16	112	2	PS51233
Domain	LamNT	NTN3 NTNG2	4.05e-03	16	112	2	SM00136
Domain	VWD	SSPOP MUC6	4.05e-03	16	112	2	SM00216
Domain	LAMININ_NTER	NTN3 NTNG2	4.05e-03	16	112	2	PS51117
Domain	Laminin_N	NTN3 NTNG2	4.05e-03	16	112	2	PF00055
Domain	VWD	SSPOP MUC6	4.05e-03	16	112	2	PF00094
Domain	EMI	SSPOP MEGF6	4.57e-03	17	112	2	PS51041
Domain	CUB_dom	ADAMTS13 ZZEF1 SCUBE3	4.85e-03	57	112	3	IPR000859
Domain	EGF-like_CS	NTN3 NTNG2 FBN1 MEGF6 SCUBE3 FBN3	4.90e-03	261	112	6	IPR013032
Domain	ZF_ZZ_2	ZSWIM2 ZZEF1	5.12e-03	18	112	2	PS50135
Domain	ZF_ZZ_1	ZSWIM2 ZZEF1	5.12e-03	18	112	2	PS01357
Domain	ZZ	ZSWIM2 ZZEF1	5.12e-03	18	112	2	PF00569
Domain	VWC_out	SSPOP MUC6	5.70e-03	19	112	2	SM00215
Domain	Znf_ZZ	ZSWIM2 ZZEF1	5.70e-03	19	112	2	IPR000433
Domain	ZnF_ZZ	ZSWIM2 ZZEF1	5.70e-03	19	112	2	SM00291
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PDE2A CHCHD5 POLR2A FBXL14 ZZEF1 HDAC7 KCNH3 NOD2 MEGF6 MTHFR ANKRD34A PYGB CACNA1H WDR90 ZNF687	3.81e-06	1105	115	15	35748872
Pubmed	NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.	NOD2 TLR2	1.08e-05	2	115	2	15214053
Pubmed	The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.	TPSAB1 TPSB2	1.08e-05	2	115	2	10500112
Pubmed	Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction.	NOD2 TLR2	1.08e-05	2	115	2	20441518
Pubmed	Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2.	NOD2 TLR2	1.08e-05	2	115	2	17563761
Pubmed	NFκB and MAPK signalling pathways mediate TNFα-induced Early Growth Response gene transcription leading to aromatase expression.	EGR2 EGR3	1.08e-05	2	115	2	23485457
Pubmed	Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog.	TPSAB1 TPSB2	1.08e-05	2	115	2	10898108
Pubmed	NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation.	NOD2 TLR2	1.08e-05	2	115	2	26388234
Pubmed	Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan.	NOD2 TLR2	1.08e-05	2	115	2	19830732
Pubmed	Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.	TPSAB1 TPSB2	1.08e-05	2	115	2	9521329
Pubmed	Invasive Streptococcus mutans induces inflammatory cytokine production in human aortic endothelial cells via regulation of intracellular toll-like receptor 2 and nucleotide-binding oligomerization domain 2.	NOD2 TLR2	1.08e-05	2	115	2	27004566
Pubmed	Nucleotide-binding oligomerization domain 2 and Toll-like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycan.	NOD2 TLR2	1.08e-05	2	115	2	20131263
Pubmed	Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.	TPSAB1 TPSB2	1.08e-05	2	115	2	10391906
Pubmed	Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection.	NOD2 TLR2	1.08e-05	2	115	2	27312104
Pubmed	Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes.	NOD2 TLR2	1.08e-05	2	115	2	20949035
Pubmed	Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation.	EGR2 EGR3	1.08e-05	2	115	2	28487311
Pubmed	Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity.	EGR2 EGR3	1.08e-05	2	115	2	27856665
Pubmed	Nod2 deficiency impairs inflammatory and epithelial aspects of the cutaneous wound-healing response.	NOD2 TLR2	1.08e-05	2	115	2	22951952
Pubmed	Characterization of a tryptase mRNA expressed in the human basophil cell line KU812.	TPSAB1 TPSB2	1.08e-05	2	115	2	8434231
Pubmed	Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance.	NOD2 TLR2	1.08e-05	2	115	2	21387014
Pubmed	EGR3 as a potential susceptibility gene for schizophrenia in Korea.	EGR2 EGR3	1.08e-05	2	115	2	20687139
Pubmed	Egr-2 and Egr-3 are negative regulators of T cell activation.	EGR2 EGR3	1.08e-05	2	115	2	15834410
Pubmed	Aberrant Expression of Bacterial Pattern Recognition Receptor NOD2 of Basophils and Microbicidal Peptides in Atopic Dermatitis.	NOD2 TLR2	1.08e-05	2	115	2	27077833
Pubmed	Transcription factors early growth response gene (Egr) 2 and 3 control inflammatory responses of tolerant T cells.	EGR2 EGR3	1.08e-05	2	115	2	29314730
Pubmed	Cloning and characterization of a second complementary DNA for human tryptase.	TPSAB1 TPSB2	1.08e-05	2	115	2	2203827
Pubmed	The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis.	NOD2 TLR2	1.08e-05	2	115	2	25549945
Pubmed	Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells.	NOD2 TLR2	1.08e-05	2	115	2	18217947
Pubmed	Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marfan syndrome patients.	FBN1 FBN3	1.08e-05	2	115	2	15221638
Pubmed	Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family.	TPSAB1 TPSB2	1.08e-05	2	115	2	2187193
Pubmed	The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation.	NOD2 TLR2	1.08e-05	2	115	2	20679445
Pubmed	Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling.	NOD2 TLR2	1.08e-05	2	115	2	21245149
Pubmed	Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.	TPSAB1 TPSB2	1.08e-05	2	115	2	15567416
Pubmed	The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells.	EGR2 EGR3	1.08e-05	2	115	2	23021953
Pubmed	The human mast cell tryptase tetramer: a fascinating riddle solved by structure.	TPSAB1 TPSB2	1.08e-05	2	115	2	10708850
Pubmed	Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.	TPSAB1 TPSB2	1.08e-05	2	115	2	17449330
Pubmed	TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular Ehrlichia infection in murine models of ehrlichiosis.	NOD2 TLR2	1.08e-05	2	115	2	23526993
Pubmed	Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia.	TPSAB1 TPSB2	1.08e-05	2	115	2	31337736
Pubmed	Adenylosuccinate lyase enhances aggressiveness of endometrial cancer by increasing killer cell lectin-like receptor C3 expression by fumarate.	ADSL KLRC3	1.08e-05	2	115	2	29467457
Pubmed	Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis.	NOD2 TLR2	1.08e-05	2	115	2	17709422
Pubmed	Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1high memory phenotype CD4 T cells.	EGR2 EGR3	1.08e-05	2	115	2	32709717
Pubmed	Retinal astrocytes pretreated with NOD2 and TLR2 ligands activate uveitogenic T cells.	NOD2 TLR2	1.08e-05	2	115	2	22808176
Pubmed	Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells.	EGR2 EGR3	1.08e-05	2	115	2	36342511
Pubmed	MARCO is required for TLR2- and Nod2-mediated responses to Streptococcus pneumoniae and clearance of pneumococcal colonization in the murine nasopharynx.	NOD2 TLR2	3.24e-05	3	115	2	23197261
Pubmed	Toll-like receptor 2 deficiency results in impaired antibody responses and septic shock during Borrelia hermsii infection.	NOD2 TLR2	3.24e-05	3	115	2	20696824
Pubmed	Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells.	NOD2 TLR2	3.24e-05	3	115	2	27624090
Pubmed	Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology.	NOD2 TLR2	3.24e-05	3	115	2	17056547
Pubmed	Uncontrolled CD21low age-associated and B1 B cell accumulation caused by failure of an EGR2/3 tolerance checkpoint.	EGR2 EGR3	3.24e-05	3	115	2	35045301
Pubmed	A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin.	WDR81 WDR91	3.24e-05	3	115	2	27126989
Pubmed	Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells.	NOD2 TLR2	3.24e-05	3	115	2	18299458
Pubmed	Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.	TPSAB1 TPSB2	3.24e-05	3	115	2	9920877
Pubmed	NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis.	NOD2 TLR2	3.24e-05	3	115	2	16322770
Pubmed	A role for TLR1, TLR2 and NOD2 in cytokine induction by Bacteroides fragilis.	NOD2 TLR2	3.24e-05	3	115	2	22998942
Pubmed	Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors.	EGR2 EGR3	3.24e-05	3	115	2	19706684
Pubmed	Early growth response transcriptional regulators are dispensable for macrophage differentiation.	EGR2 EGR3	3.24e-05	3	115	2	17312150
Pubmed	TLR2 and NODs1 and 2 cooperate in inflammatory responses associated with renal ischemia reperfusion injury.	NOD2 TLR2	3.24e-05	3	115	2	31760144
Pubmed	Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.	EGR2 EGR3	3.24e-05	3	115	2	15173177
Pubmed	Early growth response genes 2 and 3 induced by AP-1 and NF-κB modulate TGF-β1 transcription in NK1.1- CD4+ NKG2D+ T cells.	EGR2 EGR3	3.24e-05	3	115	2	33011290
Pubmed	RECQ5 helicase promotes resolution of conflicts between replication and transcription in human cells.	POLR1A POLR2A	3.24e-05	3	115	2	27502483
Pubmed	Egr2 and 3 Inhibit T-bet-Mediated IFN-γ Production in T Cells.	EGR2 EGR3	3.24e-05	3	115	2	28455436
Pubmed	Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.	EGR2 EGR3	3.24e-05	3	115	2	27911796
Pubmed	Early Growth Response Genes 2 and 3 Regulate the Expression of Bcl6 and Differentiation of T Follicular Helper Cells.	EGR2 EGR3	3.24e-05	3	115	2	25979336
Pubmed	Muramyl dipeptide potentiates staphylococcal lipoteichoic acid induction of cyclooxygenase-2 expression in macrophages.	NOD2 TLR2	3.24e-05	3	115	2	24211871
Pubmed	Identification and comparative expression analyses of Daam genes in mouse and Xenopus.	EGR2 DAAM2	3.24e-05	3	115	2	15533824
Pubmed	Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.	TPSAB1 TPSB2	3.24e-05	3	115	2	19748655
Pubmed	TLR2- and nucleotide-binding oligomerization domain 2-dependent Krüppel-like factor 2 expression downregulates NF-kappa B-related gene expression.	NOD2 TLR2	3.24e-05	3	115	2	20525885
Pubmed	A DNA pooling-based case-control study of myopia candidate genes COL11A1, COL18A1, FBN1, and PLOD1 in a Chinese population.	FBN1 PLOD1	6.48e-05	4	115	2	21527992
Pubmed	Nod1/Nod2-mediated recognition plays a critical role in induction of adaptive immunity to anthrax after aerosol exposure.	NOD2 TLR2	6.48e-05	4	115	2	19620350
Pubmed	Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly.	FBN1 FBN3	6.48e-05	4	115	2	25034023
Pubmed	Dynamic patterned expression of orphan nuclear receptor genes RORalpha and RORbeta in developing mouse forebrain.	LHX9 RORA	6.48e-05	4	115	2	12966220
Pubmed	Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity.	NOD2 TLR2	6.48e-05	4	115	2	21236705
Pubmed	Negative regulation of phosphatidylinositol 3-phosphate levels in early-to-late endosome conversion.	WDR81 WDR91	6.48e-05	4	115	2	26783301
Pubmed	Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.	NOD2 TLR2	6.48e-05	4	115	2	22750073
Pubmed	Bacterial secretion system skews the fate of Legionella-containing vacuoles towards LC3-associated phagocytosis.	TLR2 RUBCN	6.48e-05	4	115	2	28317932
Pubmed	Multiple osteoporosis susceptibility genes on chromosome 1p36 in Chinese.	MTHFR PLOD1	6.48e-05	4	115	2	19442614
Pubmed	Ataxin-3 Links NOD2 and TLR2 Mediated Innate Immune Sensing and Metabolism in Myeloid Cells.	NOD2 TLR2	6.48e-05	4	115	2	31379806
Pubmed	IFN-gamma enhances production of nitric oxide from macrophages via a mechanism that depends on nucleotide oligomerization domain-2.	NOD2 TLR2	6.48e-05	4	115	2	16585574
Pubmed	An amphioxus Krox gene: insights into vertebrate hindbrain evolution.	EGR2 EGR3	6.48e-05	4	115	2	11180801
Pubmed	Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform.	NOD2 TLR2	6.48e-05	4	115	2	29734365
Pubmed	EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.	EGR2 EGR3	6.48e-05	4	115	2	20506119
Pubmed	Phagosomal degradation increases TLR access to bacterial ligands and enhances macrophage sensitivity to bacteria.	NOD2 TLR2	6.48e-05	4	115	2	22031762
Pubmed	Immediate early genes krox-24 and krox-20 are rapidly up-regulated after wounding in the embryonic and adult mouse.	EGR2 EGR3	6.48e-05	4	115	2	11891986
Pubmed	NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.	NOD2 TLR2	6.48e-05	4	115	2	17915219
Pubmed	NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.	NOD2 TLR2	6.48e-05	4	115	2	17258734
Pubmed	NOD2 up-regulates TLR2-mediated IL-23p19 expression via NF-κB subunit c-Rel in Paneth cell-like cells.	NOD2 TLR2	6.48e-05	4	115	2	27563808
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRMPD1 KLHL32 ADCY6 IGDCC4 PXDN DAAM2 CACNA1H RUBCN	6.53e-05	407	115	8	12693553
Pubmed	Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells.	EGR2 EGR3	1.08e-04	5	115	2	29728568
Pubmed	Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk.	NOD2 TLR2	1.08e-04	5	115	2	20646321
Pubmed	Polymorphisms of genes involved in innate immunity: association with preterm delivery.	NOD2 TLR2	1.08e-04	5	115	2	15516360
Pubmed	HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter.	EGR2 EGR3	1.08e-04	5	115	2	11909874
Pubmed	Integrated analysis of DNA methylation and RNA‑sequencing data in Down syndrome.	EGR2 EGR3	1.08e-04	5	115	2	27667480
Pubmed	Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.	EGR2 EGR3	1.08e-04	5	115	2	18203138
Pubmed	Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2.	NOD2 TLR2	1.08e-04	5	115	2	17652449
Pubmed	Induction of type I interferon signaling determines the relative pathogenicity of Staphylococcus aureus strains.	NOD2 TLR2	1.08e-04	5	115	2	24586160
Pubmed	Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.	TPSAB1 TPSB2	1.08e-04	5	115	2	10843716
Pubmed	Id3 Restricts γδ NKT Cell Expansion by Controlling Egr2 and c-Myc Activity.	EGR2 EGR3	1.08e-04	5	115	2	30012846
Pubmed	The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells.	EGR2 EGR3	1.08e-04	5	115	2	19169262
Pubmed	Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16.	TPSAB1 CACNA1H WDR90 TPSB2	1.09e-04	74	115	4	11157797
Pubmed	The T300A Crohn's disease risk polymorphism impairs function of the WD40 domain of ATG16L1.	NOD2 TLR2	1.61e-04	6	115	2	27273576
Pubmed	Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis.	NOD2 TLR2	1.61e-04	6	115	2	16949315
Pubmed	Altered gene expression of the N-methyl-D-aspartate receptor channel subunits in Purkinje cells of the staggerer mutant mouse.	GRIN2C RORA	1.61e-04	6	115	2	8996814
Cytoband	16p13.3	TPSAB1 NTN3 CEMP1 CACNA1H WDR90 TPSB2	3.68e-05	244	115	6	16p13.3
Cytoband	1p36.3	MEGF6 MTHFR	5.55e-04	14	115	2	1p36.3
Cytoband	Ensembl 112 genes in cytogenetic band chr16p13	TPSAB1 NTN3 CEMP1 CACNA1H WDR90 TPSB2	7.41e-04	426	115	6	chr16p13
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF142 ZNF473 ZNF397 ZNF230 ZNF675 EGR2 EGR3 ZNF558 SP6 PRDM12 ZNF304	1.73e-04	718	75	11	28
GeneFamily	Netrins	NTN3 NTNG2	2.52e-04	6	75	2	661
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	TPSAB1 WNT9B WDR81 HDAC7 IGDCC4 MEGF6 EGR3	5.95e-07	188	115	7	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	PLVAP PRICKLE1 HDAC7 NTNG2 PXDN TM4SF1	6.09e-06	174	115	6	b4f3f5334803e5903bc496decf923f2e44f7fa3c
ToppCell	distal-1-Hematologic-EREG+_Dendritic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PDE2A ACRBP SCLY KCNH3 TLR2 ANKRD34A	1.31e-05	199	115	6	15249f2f48b1e99d9d062835fd4c705a159e4abb
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLVAP WDR91 EGR2 EGR3 TLR2 XAF1	1.31e-05	199	115	6	e245851a5bddf56f7e13a7fb7c5fda2fd275dae3
ToppCell	distal-Hematologic-EREG+_Dendritic-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PDE2A ACRBP SCLY ZZEF1 KCNH3 ANKRD34A	1.35e-05	200	115	6	7809c74a2e52768854b66a135522138281bc4449
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ADCK1 GRIN2C NOD2 MUC6 MOCS1	4.13e-05	148	115	5	1186ee0d15244fee74c1d09df3967c1b69f8ddce
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NTNG2 EGR3 MYL10 TPSB2 RGL4	4.54e-05	151	115	5	b698ddc74565d47892c09c3f16d78038da2dd5e7
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	FSTL3 ASIC1 WFS1 PXDN TPSB2	5.98e-05	160	115	5	58ed3a074932ccc951e07868dfdc61b99ae1cc2b
ToppCell	BAL-Mild-cDC_5\|Mild / Compartment, Disease Groups and Clusters	MZB1 FBN1 EGR2 EGR3 ENDOV	6.16e-05	161	115	5	7a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACRBP NTNG2 SLC17A8 ALOXE3 EDRF1	6.53e-05	163	115	5	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLVAP NTN3 PCSK6 PLOD1 RUBCN	6.92e-05	165	115	5	50a8513d8d2630861499393a7f102b35366bad37
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE2A PLVAP HDAC7 FBN1 XAF1	7.12e-05	166	115	5	9d4b44eb56ad38c26aed73444edf389abca6bdf6
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRM2 KCNH3 LHX9 SLC17A8 ALOXE3	7.33e-05	167	115	5	3dfec2fcc36caa6e394efae5e540a6fa28759977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRM2 KCNH3 LHX9 SLC17A8 ALOXE3	7.33e-05	167	115	5	95b3b5ba3414729f0460a26a0deca48de0cbe33e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRM2 KCNH3 LHX9 SLC17A8 ALOXE3	7.33e-05	167	115	5	9480739587d51e67a281778b9bddd7b5ffc3ad92
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5\|TCGA-Bladder / Sample_Type by Project: Shred V9	FRMPD1 GRIN2C KLHL32 KCNH3 FBN3	7.75e-05	169	115	5	9c4e83fe8225d16173a103bf5a57b17d623be923
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	WFS1 ADCY6 PXDN CACNA1H MUC6	8.42e-05	172	115	5	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	facs-Lung-Endomucin-24m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FSTL3 ADAMTS13 FBN1 SCUBE3 TRIM36	8.65e-05	173	115	5	a37f38478473290fe35aea8684befc3bf95b161f
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A STON1 MZB1 HDAC7 MYL10	8.89e-05	174	115	5	268be5e7d2a18b866770b7cdb966c3958c7e6534
ToppCell	facs-Heart-LV-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMD1 LYZL4 ADCY6 ANKRD34A PGBD5	8.89e-05	174	115	5	a0a059bb2a64d7011e206db2ebcdf3eb655a925a
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A STON1 MZB1 HDAC7 MYL10	8.89e-05	174	115	5	4cdf2eedc28d88d18241ee390092426fdf849e79
ToppCell	facs-Heart-LV-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMD1 LYZL4 ADCY6 ANKRD34A PGBD5	8.89e-05	174	115	5	7cd6f9103133f8d7b90f9ff4b3b0b078cf554542
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDE2A PLVAP WNT9B MEGF6 TM4SF1	9.13e-05	175	115	5	2e54961846c65b185d9bd6e305dd81205579d890
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDE2A PLVAP WNT9B MEGF6 TM4SF1	9.13e-05	175	115	5	efa6a05f7417d46141b6e635f258c126b7a03aa1
ToppCell	NS-moderate-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PLVAP FSTL3 FBN1 DAAM2 MOCS1	9.13e-05	175	115	5	f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOK6 FSTL3 NTNG2 DAAM2 MOCS1	9.63e-05	177	115	5	68263456a3c93cd195b321b309ff59e156d732fe
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_1\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOK6 FSTL3 NTNG2 DAAM2 MOCS1	9.63e-05	177	115	5	e415e448c37adc102d766235e9953dec32c021f1
ToppCell	control-Others-CD34+_GATA2+_cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TPSAB1 ADCY6 FBN1 TM4SF1 TPSB2	9.89e-05	178	115	5	2120bd3e099b0b271bf079db9827a2f3eee2f909
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Proliferative_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	PDE2A PLVAP HDAC7 EGR3 TM4SF1	1.02e-04	179	115	5	d24513a404c9b1d37dd47aa1cdb5713b64b88f89
ToppCell	3'_v3-blood-Myeloid_Dendritic-pDC\|blood / Manually curated celltypes from each tissue	PLVAP MZB1 PACSIN1 RUBCN FBN3	1.07e-04	181	115	5	66d890a105f955dca91d6e5e6c730d1a68ee9233
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 PRICKLE1 PXDN XAF1 TM4SF1	1.10e-04	182	115	5	000ff26c51c6a1ea8770c02722523e55be83b46f
ToppCell	facs-Lung-Endomucin-24m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A ADAMTS13 FBN1 SCUBE3 TRIM36	1.10e-04	182	115	5	be9c312a44868d4ee266a64d066feb8c5bce5687
ToppCell	facs-Lung-Endomucin-24m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A ADAMTS13 FBN1 SCUBE3 TRIM36	1.10e-04	182	115	5	74dbb706bcaa0f8c922bf3b0424bce5bb27167fa
ToppCell	facs-Liver-Liver_non-hepato/SCs_st\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 PRICKLE1 PXDN XAF1 TM4SF1	1.10e-04	182	115	5	b906e6e584ecbe92d3030bbdc4426f244fbe0045
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FSTL3 IGDCC4 PCSK6 ZNF558 CACNA1H	1.19e-04	185	115	5	1b990e3089772be2b38c6d7ea0d1bf22461ae3ea
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRICKLE1 FBN1 PXDN PCSK6 RORA	1.19e-04	185	115	5	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	DOK6 ADCY6 DAAM2 CACNA1H MOCS1	1.19e-04	185	115	5	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PRICKLE1 HDAC7 TM4SF1 MUC6	1.19e-04	185	115	5	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	AT1_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FSTL3 WFS1 PXDN TM4SF1 FBN3	1.25e-04	187	115	5	f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCell	P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PDE2A PLVAP WNT9B MEGF6 TM4SF1	1.28e-04	188	115	5	5eb107122064f0a99dfd445cc87d3766f7257216
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A STON1 PRICKLE1 HDAC7 TM4SF1	1.28e-04	188	115	5	0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOK6 DAAM2 CACNA1H ASB4 MOCS1	1.28e-04	188	115	5	ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCell	3'_v3-GI_small-bowel\|World / Manually curated celltypes from each tissue	TPSAB1 RORA KLRC3 TPSB2 RGL4	1.28e-04	188	115	5	822c6abaf7bcd6721269bdbd1f2b286ccf0aec1a
ToppCell	5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A PRICKLE1 WFS1 SSPOP CFAP46	1.28e-04	188	115	5	524a12f433c7b6f33fad36c0716afa06cd3235e9
ToppCell	5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE2A PRICKLE1 WFS1 SSPOP CFAP46	1.28e-04	188	115	5	d2610b81b3c7f22977b5e2137b1f61410fc4ef16
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDE2A PLVAP FBN1 MEGF6 TM4SF1	1.31e-04	189	115	5	d17e8467699c7ca7694a313c26111f085df5204e
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PACSIN1 KCNH3 CACNA1H DIXDC1	1.31e-04	189	115	5	5a0fd34928117f162c83ca1b068aa8f7069a6765
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A STON1 PRICKLE1 HDAC7 TM4SF1	1.34e-04	190	115	5	a08c5929b05a4969852e351a93c4e4deb4c8d5b6
ToppCell	PND01-03-samps-Endothelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	PLVAP PRICKLE1 HDAC7 PXDN TM4SF1	1.34e-04	190	115	5	1357bd4527399d7013ee33272bda7453f472999a
ToppCell	P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PDE2A PLVAP WNT9B MEGF6 TM4SF1	1.34e-04	190	115	5	d072bb285bd34d518b958e7c9ad44739c60b359c
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A STON1 PRICKLE1 HDAC7 TM4SF1	1.34e-04	190	115	5	25525fee1da8a808034d9c916159fd0b6b26bce8
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	PLVAP PRICKLE1 HDAC7 PXDN TM4SF1	1.34e-04	190	115	5	5130fb325f80f591b9b36beacb8072c4472304f2
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PRICKLE1 HDAC7 PXDN TM4SF1	1.38e-04	191	115	5	1924af7d8b0a0b892e480a9fd6d874941b0c0b5d
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PRICKLE1 HDAC7 PXDN TM4SF1	1.38e-04	191	115	5	88f91e57a1409bdeb91e9bf47510a6fb998a1bf5
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PRICKLE1 APLP1 LHX9 SCUBE3 TM4SF1	1.41e-04	192	115	5	d88753b200d9c8da6716222d697ddf0a1548d6c8
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PRICKLE1 HDAC7 PXDN TM4SF1	1.41e-04	192	115	5	5890076929598e88fe9d59a4e4e858b446746ce9
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PRICKLE1 HDAC7 PXDN TM4SF1	1.44e-04	193	115	5	4a8c97ff2dffc5c06351d1cb107e21e58250aa55
ToppCell	droplet-Liver-HEPATOCYTES-1m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PRICKLE1 HDAC7 PXDN TM4SF1	1.44e-04	193	115	5	d5f6d6e2c36d4e80af4d39cdfc0b18df295a587b
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PDE2A PLVAP PXDN PCSK6 TM4SF1	1.44e-04	193	115	5	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDE2A PLVAP GRM2 SP6 TM4SF1	1.48e-04	194	115	5	8a4be91414a2e69dd410aa75791f16008204c9a1
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	PRICKLE1 FBN1 PXDN PCSK6 RORA	1.48e-04	194	115	5	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOK6 FSTL3 CACNA1H PLOD1 MOCS1	1.48e-04	194	115	5	f95935153bd2c4c3c7b2b729da6f7e98b45fed79
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PLVAP PRICKLE1 PXDN TM4SF1	1.52e-04	195	115	5	f55ab1018a6cde7d517b53e6ce44c3f7bde485c4
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PLVAP PRICKLE1 PXDN TM4SF1	1.52e-04	195	115	5	ea1b00805391dca8be0883b635768b296369919a
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PRICKLE1 HDAC7 PXDN TM4SF1	1.52e-04	195	115	5	12ba6d95e42d06b1991b011043c0e3370a7b4131
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PLVAP PRICKLE1 PXDN TM4SF1	1.52e-04	195	115	5	85df110f753f58ab017018c54ee454edb4428e29
ToppCell	mild-B_cell\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KLHL2 LIMD1 INTS7 ZZEF1 WDR91	1.52e-04	195	115	5	1e5f1967bcc898318f4e970b844b4a944eb168e5
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ESRRG RORA TM4SF1 TPSB2 CFAP46	1.55e-04	196	115	5	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ESRRG RORA TM4SF1 TPSB2 CFAP46	1.55e-04	196	115	5	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	proximal-Endothelial-Capillary-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DOK6 FBXL14 NOD2 SP6 TM4SF1	1.59e-04	197	115	5	ddb8ea895f0f34d4f20a0740b708fa0f3e378801
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	APLP1 GRM2 FBN1 EGR3 TM4SF1	1.59e-04	197	115	5	ad4a3b5da2190be9495382a2952991e1de9f190d
ToppCell	proximal-Endothelial-Capillary\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DOK6 FBXL14 NOD2 SP6 TM4SF1	1.59e-04	197	115	5	53baef54bd85c60ae24a3c163b3a3d937fb6ff0b
ToppCell	mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma\|mLN / shred on region, Cell_type, and subtype	MZB1 SSPOP ADCY6 FBN1 PXDN	1.59e-04	197	115	5	a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7
ToppCell	proximal-3-Endothelial-Capillary\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DOK6 FBXL14 NOD2 SP6 TM4SF1	1.59e-04	197	115	5	a1a61c03d67272693ec23e0d15f0a12bf618e2da
ToppCell	mLN-B_cell-B_cell_IgA_Plasma\|mLN / Region, Cell class and subclass	MZB1 SSPOP ADCY6 FBN1 PXDN	1.59e-04	197	115	5	20822fce311326765b71337ce501ba44ea14f58f
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBN1 PXDN SCUBE3 DAAM2 TM4SF1	1.63e-04	198	115	5	09be07ebfc3e49c3858e9b74605b69cf4fc28b56
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	DOK6 FBN1 PXDN RORA TM4SF1	1.67e-04	199	115	5	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DOK6 DAAM2 CACNA1H PLOD1 MOCS1	1.71e-04	200	115	5	d70bad979299615fcba707ba21296020918705e6
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	LIMD1 ACRBP PACSIN1 ARL11 PYGB	1.71e-04	200	115	5	6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DOK6 DAAM2 CACNA1H PLOD1 MOCS1	1.71e-04	200	115	5	38c21ec379005f688df33aea65237a063c476c2e
Drug	Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A	PACSIN1 APLP1 SCLY NOD2 MEGF6 PCSK6 XAF1 TM4SF1 ZNF304	6.43e-07	196	114	9	3604_UP
Drug	Arecoline hydrobromide [300-08-3]; Up 200; 17uM; MCF7; HT_HG-U133A	ASIC1 SCLY ADAMTS13 TLR2 TRIM36 MUC6 MOCS1 PCM1 ZNF304	6.71e-07	197	114	9	2657_UP
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A	NTN3 GRIN2C ZZEF1 ADCY6 CEMP1 MTHFR PCSK6 PYGB MYL10	7.00e-07	198	114	9	3059_UP
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A	PLVAP ADAMTS13 ZZEF1 PRDM12 RORA ALOXE3 XAF1 TRIM36 ZNF304	7.00e-07	198	114	9	3894_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	STON1 MTHFR PCSK6 TLR2 RORA ALOXE3 XAF1 MUC6	5.89e-06	193	114	8	5603_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A	ZNF473 MZB1 FRMPD1 ZNF230 CEMP1 FBN1 MEGF6 MTHFR	6.36e-06	195	114	8	4705_UP
Drug	Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	ASIC1 ZZEF1 HDAC7 MTHFR PRDM12 CACNA1H TRIM36 TM4SF1	6.60e-06	196	114	8	2233_UP
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A	ASIC1 ADAMTS13 PCSK6 ALOXE3 MOCS1 EDRF1 PGBD5 PCM1	6.60e-06	196	114	8	3965_DN
Drug	Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	FRMPD1 APLP1 ADAMTS13 ZZEF1 HDAC7 ADCY6 FBN1 TM4SF1	6.85e-06	197	114	8	3551_UP
Drug	Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ZNF230 ZZEF1 MTHFR CACNA1H TRIM36 PGBD5 PCM1 ZNF304	6.85e-06	197	114	8	3447_UP
Drug	Chlorhexidine [55-56-1]; Up 200; 8uM; MCF7; HT_HG-U133A	STON1 NTN3 ADAMTS13 ZZEF1 HDAC7 RORA CACNA1H TM4SF1	6.85e-06	197	114	8	5403_UP
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	GRM2 NOD2 CEMP1 WDR91 MTHFR TLR2 MYL10 MOCS1	6.85e-06	197	114	8	6497_UP
Drug	Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A	ZNF473 APLP1 ADAMTS13 MTHFR PCSK6 TLR2 CACNA1H TRIM36	7.38e-06	199	114	8	1511_UP
Drug	0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A	PLVAP FRMPD1 SCLY ADAMTS13 ZNF230 MEGF6 XAF1 TM4SF1	7.38e-06	199	114	8	3633_UP
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	STON1 GRM2 FBN1 MEGF6 PCSK6 PRDM12 EDRF1	4.27e-05	186	114	7	4463_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	STON1 APLP1 ZNF230 ALOXE3 DIXDC1 TRIM36 PGBD5	5.23e-05	192	114	7	5206_UP
Drug	Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A	ZNF473 ASIC1 HDAC7 NOD2 PCSK6 TLR2 RORA	5.58e-05	194	114	7	5398_UP
Drug	Atovaquone [95233-18-4]; Up 200; 11uM; MCF7; HT_HG-U133A	FRMPD1 ADCY6 CEMP1 FBN1 MEGF6 CACNA1H TM4SF1	5.58e-05	194	114	7	4786_UP
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	ESRRG HDAC7 FBN1 HEATR6 TLR2 EDRF1 PCM1	5.95e-05	196	114	7	3796_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; HL60; HT_HG-U133A	SCLY ZNF675 PCSK6 PYGB EDRF1 PGBD5 PCM1	5.95e-05	196	114	7	2430_UP
Drug	clozapine; Down 200; 10uM; HL60; HT_HG-U133A	ZNF473 ZZEF1 EGR3 PRDM12 PYGB EDRF1 PCM1	6.15e-05	197	114	7	2689_DN
Drug	Cinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	INTS7 ASIC1 ZNF230 ADCY6 WDR91 EGR3 PCM1	6.15e-05	197	114	7	7174_UP
Drug	Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ASIC1 POLR2A ADAMTS13 GRM2 CACNA1H DIXDC1 TM4SF1	6.15e-05	197	114	7	2869_UP
Drug	Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; PC3; HT_HG-U133A	STON1 ZZEF1 CEMP1 MEGF6 TLR2 XAF1 MUC6	6.15e-05	197	114	7	4668_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ASIC1 FRMPD1 PCSK6 DIXDC1 MYL10 TM4SF1 PGBD5	6.15e-05	197	114	7	2326_DN
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; MCF7; HT_HG-U133A	FSTL3 PACSIN1 APLP1 HDAC7 PCSK6 RORA DIXDC1	6.35e-05	198	114	7	5434_UP
Drug	Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A	FRMPD1 CEMP1 MTHFR PCSK6 TM4SF1 MOCS1 ZNF304	6.35e-05	198	114	7	7233_UP
Drug	Halcinonide [3093-35-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A	FRMPD1 HDAC7 MEGF6 MTHFR DIXDC1 TM4SF1 EDRF1	6.35e-05	198	114	7	4703_UP
Drug	Nicergoline; Up 200; 8.2uM; MCF7; HT_HG-U133A	MZB1 ASIC1 PACSIN1 FRMPD1 MTHFR ALOXE3 MYL10	6.35e-05	198	114	7	2220_UP
Drug	Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	STON1 ESRRG CEMP1 PCSK6 ALOXE3 MYL10 MOCS1	6.35e-05	198	114	7	4235_UP
Drug	thymidine glycol	TPSAB1 ENDOV TPSB2	6.53e-05	16	114	3	CID003035041
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A	APLP1 SCLY HDAC7 CACNA1H DIXDC1 MOCS1 PGBD5	6.55e-05	199	114	7	3346_DN
Drug	thymidine glycol monophosphate	TPSAB1 TPSB2	7.43e-05	3	114	2	CID000165415
Disease	tryptase beta-2 measurement	TPSAB1 CACNA1H TPSB2	4.05e-06	9	109	3	EFO_0008306
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN3	4.05e-05	3	109	2	DOID:65 (implicated_via_orthology)
Disease	Bipolar Disorder	WFS1 NOD2 NTNG2 EGR2 EGR3 MTHFR TLR2 RORA DIXDC1	7.15e-05	477	109	9	C0005586
Disease	meningococcal meningitis (is_implicated_in)	NOD2 TLR2	8.07e-05	4	109	2	DOID:0080176 (is_implicated_in)
Disease	Anencephaly	MTHFR TRIM36	8.07e-05	4	109	2	C0002902
Disease	systemic mastocytosis	TPSAB1 MEGF6 MOCS1	1.06e-04	25	109	3	MONDO_0016586
Disease	leprosy (is_implicated_in)	NOD2 TLR2	3.73e-04	8	109	2	DOID:1024 (is_implicated_in)
Disease	Autistic Disorder	ADSL EGR2 MTHFR RORA CACNA1H DIXDC1	4.28e-04	261	109	6	C0004352
Disease	Schizophrenia	GRIN2C GRM2 NDUFS1 NTNG2 EGR2 EGR3 MTHFR TLR2 DAAM2 DIXDC1 PCM1	4.32e-04	883	109	11	C0036341
Disease	familial Mediterranean fever (is_implicated_in)	NOD2 MTHFR	4.79e-04	9	109	2	DOID:2987 (is_implicated_in)
Disease	Varicose veins	WNT9B HDAC7 LHX9 PCSK6 RORA	7.66e-04	193	109	5	HP_0002619
Disease	Hereditary Diffuse Gastric Cancer	NDUFS1 KISS1R MTHFR RORA XAF1 MUC6	7.84e-04	293	109	6	C1708349
Disease	Stomach Neoplasms	NDUFS1 KISS1R MTHFR RORA XAF1 MUC6	8.41e-04	297	109	6	C0038356
Disease	Malignant neoplasm of stomach	NDUFS1 KISS1R MTHFR RORA XAF1 MUC6	8.86e-04	300	109	6	C0024623
Disease	allergic rhinitis (is_marker_for)	NOD2 TLR2	1.77e-03	17	109	2	DOID:4481 (is_marker_for)
Disease	high altitude adaptation	LHX9 MTHFR	1.77e-03	17	109	2	EFO_0009105
Disease	graft-versus-host disease (is_implicated_in)	NOD2 MTHFR	1.77e-03	17	109	2	DOID:0081267 (is_implicated_in)
Disease	Manic Disorder	NTNG2 MTHFR DIXDC1	2.34e-03	71	109	3	C0024713
Disease	urticaria	TPSAB1 TPSB2	2.46e-03	20	109	2	EFO_0005531
Disease	Nonsyndromic genetic hearing loss	WFS1 PTPRQ SLC17A8	2.83e-03	76	109	3	cv:C5680182
Disease	Manic	NTNG2 MTHFR DIXDC1	3.05e-03	78	109	3	C0338831
Disease	Depression, Bipolar	NTNG2 MTHFR DIXDC1	3.16e-03	79	109	3	C0005587
Disease	age of onset of asthma	HDAC7 SCUBE3 RORA	3.16e-03	79	109	3	OBA_2001001

Protein segments in the cluster

Peptide	Gene	Start	Entry
FLNMSRCCIRALAEH	ADCK1	461	Q86TW2
MFTCNHTPIRSCAAR	ADCY6	761	O43306
VCCNSPRTLMHLSRC	ASB4	376	Q9Y574
CDSLGRRHMSTCALC	ACRBP	361	Q8NEB7
RRHMSTCALCDFCSL	ACRBP	366	Q8NEB7
AALADVCHDMSRSGR	DIXDC1	161	Q155Q3
HRALCPNTTRLCDAM	GRM2	396	Q14416
VVTLRCNHRDASMLG	GRM2	716	Q14416
CRFLHQERMDQCESS	APLP1	156	P51693
QFLGRAHLCRAQMCA	CFAP46	81	Q8IYW2
MCHTDLCRLLLQQGA	ANKRD24	191	Q8TF21
GRDVDECRMLAHLCA	FBN3	2361	Q75N90
HSQGDALCRHMCRAI	ADAMTS13	476	Q76LX8
ALCRHMCRAIGESFI	ADAMTS13	481	Q76LX8
NIADRLGRTALMHAC	ANKRD34A	71	Q69YU3
LACMCAGLRRSPHRE	IGDCC4	971	Q8TDY8
QCRICMRNFSRSDHL	EGR2	371	P11161
AQDAARILMCHCLAA	INTS7	441	Q9NVH2
SRAEVMQRGCACSFL	KCNH3	56	Q9ULD8
RSCMCLQARAHGAER	ARL11	176	Q969Q4
CLLNFLRSMDHATCE	DAAM2	156	Q86T65
HCSMLLRTGTVFERC	MUC6	591	Q6W4X9
LHMTCCRQRLEEITG	MTHFR	126	P42898
DHGRNRCHMSCSALL	LYZL4	86	Q96KX0
QQSADRCFLCGHLIM	LIMD1	531	Q9UGP4
TGRLMRICAQAHCGA	EDRF1	906	Q3B7T1
YSTSTDCREHCRRGM	HHLA3	61	Q9XRX5
CTHLLCEAFAMATLR	ALOXE3	411	Q9BYJ1
SNSNMRCTCRIIEDG	PCM1	1536	Q15154
LHCGDKNSRCRSEMN	PCSK6	171	P29122
LGSELASIRRACDHM	PLVAP	261	Q9BX97
QRCARCHLGISASEM	LHX9	131	Q9NQ69
ISCMCHDLDHRGTNN	PDE2A	691	O00408
RLCQTSHRFAKLCMS	FBXO36	116	Q8NEA4
VRRAAVHCMANLCLS	HEATR6	181	Q6AI08
CACYAAMLRHLGRVA	KISS1R	221	Q969F8
SFHRNSFQCGIMCLR	PPFIA1	1011	Q13136
ERNGMISAHCNLCLT	MYL10	66	Q9BUA6
GRMRCVICHRGFNSR	PRDM12	241	Q9H4Q4
SLCSCHISDDGINRM	FBXL14	311	Q8N1E6
SMSEHFCGTCNRLRI	MOCS1	306	Q9NZB8
ARNMGADLCRQDRSC	PLOD1	361	Q02809
KIERHGDCMTVRQCN	PTPRQ	2181	Q9UMZ3
RIDDGHRLCNDLMNC	PACSIN1	31	Q9BY11
MRTHTGIRPFRCSAC	OVOL3	141	O00110
CSCNGHARRCRFNME	NTN3	311	O00634
LLSRAVMHAVCEQCG	PRICKLE1	116	Q96MT3
LHSMVARSLCRNAAG	PGBD5	321	Q8N414
CITTSCLGDHSMRAR	RGL4	276	Q8IZJ4
MSSIRFLCQRCHQAL	BECN2	1	A8MW95
QAMARTAHILTDRCG	CCDC105	26	Q8IYK2
RSCSGSLTARVCHMG	CEMP1	216	Q6PRD7
VGNCAEHMRRFLQCA	CHCHD5	76	Q9BSY4
RAGALCAMRSFVAHC	HEATR5B	611	Q9P2D3
HLCMECLGTRLNDIS	DOK6	106	Q6PKX4
CGSRSIQHCNIRCMN	FBN1	111	P35555
SCHMRQATCFLGRSI	FSTL3	221	O95633
RLCMGSQKLLSSCRH	FRMPD1	1461	Q5SYB0
QGHSCSRKMNASRCL	GPR32P1	21	Q8NGA4
QCRICMRSFSRSDHL	EGR3	306	Q06889
LCRMSNKDRHIDSSC	ESRRG	21	P62508
CCSLGRSCHLHSFMR	GIMD1	46	P0DJR0
VGHRMSLEAAVRLTC	ENDOV	211	Q8N8Q3
QDRLARCTMHCNDKA	FAM136A	76	Q96C01
SVMLKHQCSCGDNSR	HDAC7	526	Q8WUI4
CSSRRDNGMQKCSHI	CACNA1H	291	O95180
TRAGATHVERCMLCQ	RUBCN	871	Q92622
NTSIHRCIRCAMGSY	SCUBE3	756	Q8IX30
RNGSCMHRCQVVRGL	MEGF6	251	O75095
RCKCNLHANLCSMRE	NTNG2	286	Q96CW9
LHANLCSMREGSLQC	NTNG2	291	Q96CW9
MAALCRTRAVAAESH	MRPS28	1	Q9Y2Q9
RQAARAATAIMCDLC	TRIM36	146	Q9NQ86
RDDMLCAGNTRRDSC	TPSAB1	206	Q15661
RDDMLCAGNTRRDSC	TPSB2	206	P20231
RGSCLNCHMLTCPRA	POLR1A	101	O95602
DMCLGQSHRSRACSR	SSPOP	3486	A2VEC9
HERLSVAGNCRMCLV	NDUFS1	66	P28331
SERCCSLARHLMTLV	ADSL	301	P30566
NCAMLHVRGLISDQC	KLRC3	206	Q07444
CAVCSRVFMRSDHLA	SP6	316	Q3SY56
VCAVRHMRSSGHQRC	MRPL12	31	P52815
MPRHCSAAGCCTRDT	THAP7	1	Q9BT49
RDMLLSCHFRGEVCS	ASIC1	166	P78348
NTHLLLGMCLDACAR	TTC19	231	Q6DKK2
QCRVLMASVGAACHS	SCLY	376	Q96I15
CSRSGHILEIDCQRM	WDR90	576	Q96KV7
SLQCSHCGLRAMTGR	TMPRSS13	311	Q9BYE2
RTHMSGSCTQDRCFR	ZCCHC3	341	Q9NUD5
TDGCAHSMAKLLACR	NOD2	856	Q9HC29
NQDSLRSLSMHCLCA	STON1	241	Q9Y6Q2
RSLSMHCLCAEENAS	STON1	246	Q9Y6Q2
QHCRLQKCLAVGMSR	RORA	126	P35398
ANAARCPMSVLHRVC	WDR97	501	A6NE52
RHLALLCDTMTCRGH	POLR2A	1396	P24928
VMLENCRNLASLGCR	ZNF558	71	Q96NG5
MEGDFSVCRNCKRHV	XAF1	1	Q6GPH4
SGCTAHRRVNNCSDM	PXDN	721	Q92626
DCKRINMAHLCVIGS	PYGB	436	P11216
ARNRHCLVNMETSCS	WAPL	996	Q7Z5K2
MISAHCNLRLLCSSD	TEX11	1	Q8IYF3
HENCGKRCAMLSSVL	TM4SF1	81	P30408
ECGRSFCMLSHLTRH	ZNF675	176	Q8TD23
NCMGEITRKCSHLSR	ZSWIM2	596	Q8NEG5
CNECGKAFRHRSVLM	ZNF397	511	Q8NF99
GKSFCLRSSLNRHCM	ZNF230	286	Q9UIE0
TCDHCQGLIIGRRMN	ZZEF1	1831	O43149
SMRIEVTCNHCARRL	ZNF687	556	Q8N1G0
KSCTVHMLGRSFTCR	ZNF304	156	Q9HCX3
ETRHREARAFMCEQC	ZNF142	1556	P52746
ALTHTLARACSAGRM	WNT9B	126	O14905
HRTALVSGMCCALFL	TLR2	586	O60603
IMHCRVDCSGRRVAS	WDR91	411	A4D1P6
SHSCVGCRRERTAMA	USP11	31	P51784
MDACHRQGLACGALS	WDR81	271	Q562E7
SAARVHYGCVMCVRI	SLC17A8	176	Q8NDX2
CQECVRSFSRPSHLM	ZNF473	461	Q8WTR7
SCLNCMAQLSPTRRH	WFS1	846	O76024
CLSIQEMLTGQRLCH	KLHL32	6	Q96NJ5
VNCLGIRAFADMHAC	KLHL2	156	O95198
SAHMPAHLRCDACRA	MZB1	41	Q8WU39
HSACRRLAQAQSMCL	GRIN2C	1111	Q14957